This Article Full Text Full Text (PDF) All Versions of this Article: 2003-0105OCv1 30/4/569    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamasawa, H. Articles by Sugiyama, Y. Search for Related Content PubMed PubMed Citation Articles by Yamasawa, H. Articles by Sugiyama, Y.

Macrolides Inhibit Epithelial Cell–Mediated Neutrophil Survival by Modulating Granulocyte Macrophage Colony–Stimulating Factor Release

Division of Pulmonary Medicine, Department of Medicine, Jichi Medical School, Tochigi, Japan

Address correspondence to: Hideaki Yamasawa, M.D., Division of Pulmonary Medicine, Department of Medicine, Jichi Medical School, 3311-1 Yakushiji, Minamikawachi, Tochigi 329-0498, Japan. E-mail: hyamasa{at}jichi.ac.jp

Macrolides have been shown to be effective in treating diffuse panbronchiolitis (DPB), although the precise modes of action remain unclear. At sites of airway inflammation, respiratory epithelium is considered an active participant in regulating neutrophil survival. We therefore examined the effect of erythromycin, clarithromycin, azithromycin, and josamycin on both neutrophil survival and on epithelial-derived factors, which influence neutrophil longevity. Media conditioned with transiently tumor necrosis factor (TNF)-–stimulated A549 human airway epithelial cells prolonged neutrophil survival compared with control media. The presence of dexamethasone during neutrophil culture led to further prolongation of neutrophil survival. In contrast, none of the tested macrolides modulated neutrophil survival, suggesting a lack of direct effect of these drugs. On the other hand, pretreatment of TNF-–stimulated A549 cells by erythromycin, clarithromycin, azithromycin, or dexamethasone, but not josamycin, decreased the neutrophil survival–enhancing effects in a dose-dependent manner. Neutralizing antibodies to granulocyte macrophage colony–stimulating factor (GM-CSF) dampened the prolonged neutrophil survival observed in TNF-–stimulated A549 conditioned media. Erythromycin, clarithromycin, azithromycin, and dexamethasone inhibited TNF-–induced GM-CSF expression in A549 cells at both the protein and messenger RNA levels. These results suggest that macrolides inhibit epithelial cell–mediated neutrophil survival by modulating GM-CSF release, which may, at least in part, explain the effectiveness of this family of drugs on DPB.

Abbreviations: complementary DNA, cDNA • diffuse panbronchiolitis, DPB • enzyme-linked immunosorbent assay, ELISA • fetal calf serum, FCS • granulocyte colony-stimulating factor, G-CSF • granulocyte macrophage colony–stimulating factor, GM-CSF • interleukin, IL • lipopolysaccharide, LPS • messenger RNA, mRNA • phosphate-buffered saline, PBS • recombinant human, rh • reverse transcription-polymerase chain reaction, RT-PCR • tumor necrosis factor, TNF

This article has been cited by other articles:

				S. Hodge, G. Hodge, S. Brozyna, H. Jersmann, M. Holmes, and P. N. Reynolds Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Eur. Respir. J., September 1, 2006; 28(3): 486 - 495. [Abstract] [Full Text] [PDF]

				B. Yates, D. M. Murphy, I. A. Forrest, C. Ward, R. M. Rutherford, A. J. Fisher, J. L. Lordan, J. H. Dark, and P. A. Corris Azithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 772 - 775. [Abstract] [Full Text] [PDF]

				A. Linden, M. Laan, and G. P. Anderson Neutrophils, interleukin-17A and lung disease Eur. Respir. J., January 1, 2005; 25(1): 159 - 172. [Abstract] [Full Text] [PDF]